CIPO Patents = 2

EPO Patents = 4

Trademarks = 3

Forward Citations = 147

Loading Chart...

3 inventors (with patents filed for the assignee):

Donald Jeffrey Keyser (20 out of 36 patents)

Alvaro F Guillem (20 out of 30 patents)

Jeff Gilmore (2 out of 2 patents)

20 patents: Sort by Forward Citations

1. 12582673 - Extended use zirconium silicate compositions and methods of use thereof (2026-03-24),

2. 11738044 - Extended use zirconium silicate compositions and methods of use thereof (2023-08-29),

3. 11406662 - Microporous zirconium silicate for the treatment of hyperkalemia (2022-08-09),

4. 10695366 - Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease (2020-06-30),

5. 10695365 - Microporous zirconium silicate for the treatment of hyperkalemia (2020-06-30),

6. 10413569 - Microporous zirconium silicate for the treatment of hyperkalemia (2019-09-17),

7. 10398730 - Microporous zirconium silicate for the treatment of hyperkalemia (2019-09-03),

8. 10335432 - Microporous zirconium silicate for the treatment of hyperkalemia (2019-07-02),

9. 10300087 - Extended use zirconium silicate compositions and methods of use thereof (2019-05-28),

10. 9943637 - Microporous zirconium silicate and its method of production (2018-04-17),

11. 9913860 - Microporous zirconium silicate for the treatment of hyperkalemia (2018-03-13),

12. 9861658 - Microporous zirconium silicate for the treatment of hyperkalemia (2018-01-09),

13. 9844567 - Microporous zirconium silicate for the treatment of hyperkalemia (2017-12-19),

14. 9707255 - Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved calcium-containing compositions for the treatment of hyperkalemia (2017-07-18),

15. 9662352 - Microporous zirconium silicate for the treatment of hyperkalemia (2017-05-30),

Company Overview

Zs Pharma, Inc. is a biopharmaceutical company based in Coppell, Texas, specializing in the development of innovative therapies for patients with kidney-related conditions. The company focuses on addressing unmet medical needs through advanced research in renal pharmacology. Zs Pharma's expertise lies in formulating novel compounds aimed at improving patient outcomes in the management of chronic kidney disease and related disorders, contributing to the evolving landscape of renal health solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

20 Patents

#6 in Coppell, TX

#973 in Texas

#16,382 in US

#31,233 in the World

Coppell, TX, United States of America

Zs Pharma, Inc.

Forward Citations = 147

3 inventors:

Donald Jeffrey Keyser (20 out of 36 patents)

Alvaro F Guillem (20 out of 30 patents)

Jeff Gilmore (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zs Pharma, Inc.. Retrieved from https://idiyas.com/company/zs-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]